Skip to content

H.R. 5074 · 118th Congress (2023–2025)

Kidney PATIENT Act of 2023

This bill delays a change to the payment methodology under Medicare for oral drugs that are used to treat end-stage renal disease (ESRD).

Under current regulations, beginning January 1, 2025, the Centers for Medicare & Medicaid Services will incorporate payments for oral-only ESRD drugs into the ESRD prospective payment system rather than issuing separate payments to ESRD facilities. The bill delays implementation of this policy until January 1, 2033, or until an approved intravenous drug is available, whichever is earlier.

Show official title

To amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReported by committee

This bill’s path

This is H.R. 5074’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Earl L. "Buddy" Carter (R-GA-1)
Cosponsors
45 cosponsors

3 original · 42 later

12 R · 33 D

  1. Rep. Ann M. Kuster (D-NH-2)· Original · Jul 28, 2023
  2. Rep. Carol D. Miller (R-WV-1)· Original · Jul 28, 2023
  3. Rep. Terri A. Sewell (D-AL-7)· Original · Jul 28, 2023
  4. Rep. Donald G. Davis (D-NC-1)· Later · Oct 6, 2023
  5. Rep. Yvette D. Clarke (D-NY-9)· Later · Nov 8, 2023
  6. Rep. John Joyce (R-PA-13)· Later · Nov 13, 2023
  7. Rep. Danny K. Davis (D-IL-7)· Later · Nov 17, 2023
  8. Rep. A. Drew Ferguson IV (R-GA-3)· Later · Nov 17, 2023
  9. Rep. Blake D. Moore (R-UT-1)· Later · Nov 30, 2023
  10. Rep. Henry Cuellar (D-TX-28)· Later · Dec 4, 2023
  11. Rep. Jodey C. Arrington (R-TX-19)· Later · Dec 19, 2023
  12. Rep. Henry C. "Hank" Johnson, Jr. (D-GA-4)· Later · Jan 29, 2024
  13. Rep. Larry Bucshon (R-IN-8)· Later · Mar 20, 2024
  14. Rep. William R. Keating (D-MA-9)· Later · Jul 9, 2024
  15. Rep. Stephen F. Lynch (D-MA-8)· Later · Jul 11, 2024
  16. Rep. Jonathan L. Jackson (D-IL-1)· Later · Jul 22, 2024
  17. Rep. Seth Moulton (D-MA-6)· Later · Jul 24, 2024
  18. Rep. Jasmine Crockett (D-TX-30)· Later · Jul 30, 2024
  19. Rep. Vince Fong (R-CA-20)· Later · Jul 30, 2024
  20. Rep. Mike Thompson (D-CA-4)· Later · Aug 30, 2024
  21. Rep. David G. Valadao (R-CA-22)· Later · Sep 3, 2024
  22. Rep. Michelle Steel (R-CA-45)· Later · Sep 9, 2024
  23. Rep. Eric Swalwell (D-CA-14)· Later · Sep 10, 2024
  24. Rep. Troy A. Carter (D-LA-2)· Later · Sep 17, 2024
  25. Rep. Adriano Espaillat (D-NY-13)· Later · Sep 24, 2024
  26. Rep. Veronica Escobar (D-TX-16)· Later · Sep 24, 2024
  27. Rep. Maxine Waters (D-CA-43)· Later · Oct 1, 2024
  28. Rep. Patrick Ryan (D-NY-18)· Later · Oct 4, 2024
  29. Rep. Thomas R. Suozzi (D-NY-3)· Later · Oct 4, 2024
  30. Rep. Gabe Vasquez (D-NM-2)· Later · Oct 4, 2024
  31. Rep. Hillary J. Scholten (D-MI-3)· Later · Oct 8, 2024
  32. Rep. Mary Sattler Peltola (D-AK)· Later · Oct 11, 2024
  33. Rep. Emilia Strong Sykes (D-OH-13)· Later · Oct 11, 2024
  34. Rep. Vicente Gonzalez (D-TX-34)· Later · Oct 18, 2024
  35. Rep. Steven Horsford (D-NV-4)· Later · Oct 18, 2024
  36. Rep. Gregory W. Meeks (D-NY-5)· Later · Oct 18, 2024
  37. Rep. Nydia M. Velázquez (D-NY-7)· Later · Oct 18, 2024
  38. Rep. Ritchie Torres (D-NY-15)· Later · Oct 25, 2024
  39. Rep. Young Kim (R-CA-40)· Later · Nov 5, 2024
  40. Rep. Jahana Hayes (D-CT-5)· Later · Nov 14, 2024
  41. Rep. Chellie Pingree (D-ME-1)· Later · Nov 14, 2024
  42. Rep. Linda T. Sánchez (D-CA-38)· Later · Nov 21, 2024
  43. Rep. John R. Curtis (R-UT-3)· Later · Dec 3, 2024
  44. Rep. Richard Hudson (R-NC-9)· Later · Dec 11, 2024
  45. Rep. Gabe Amo (D-RI-1)· Later · Dec 17, 2024
Policy area
Health
Subjects
  • Digestive and metabolic diseases
  • Health care costs and insurance
  • Medicare
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 9 committee actions · Jul 28, 2023 – Jun 11, 2024
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    4. Ordered reported

      Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 1.

      Sources
    5. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held

      Sources
    6. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 16 - 10.

      Sources
    7. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    8. Ordered reported

      Ordered to be Reported (Amended) by the Yeas and Nays: 37 - 10.

      Sources
    9. Reported by committee

      Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.

      Sources
  3. Expired

    Introduced → Reported by committee → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jul 28, 2023 · Markup Mar 20, 2024
    1. Mar 20, 2024 · Markup

  2. HouseHealthReferred Aug 4, 2023 · Markup Mar 12, 2024 · Reported Mar 12, 2024
    1. Mar 12, 2024 · Markup

    2. Sep 19, 2023 · Meeting

  3. HouseWays and MeansReferred Jul 28, 2023 · Markup Mar 6, 2024 · Reported Jun 11, 2024H. Rept. 118-548
    1. Mar 6, 2024 · Markup

    1. H. Rept. 118-548 · Jun 11, 2024 · Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. Kidney PATIENT Act of 2023

    Display title, Short title · Introduced in House

  2. Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023

    Short title · Introduced in House

  3. To amend the American Taxpayer Relief Act of 2012 to delay implementation of the inclusion of oral-only ESRD-related drugs in the Medicare ESRD prospective payment system.

    Official title · Introduced in House